Slovakia: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Slovakia

The Slovak market for other medicaments for therapeutic or prophylactic uses fell to $X in 2022, shrinking by X% against the previous year. Overall, consumption, however, posted a pronounced increase. Over the period under review, the market hit record highs at $X in 2021, and then declined in the following year.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Slovakia

In value terms, production of other medicaments for therapeutic or prophylactic uses totaled $X in 2022 estimated in export price. Overall, the total production indicated a strong increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by X% against 2020 indices. The pace of growth appeared the most rapid in 2016 when the production volume increased by X% against the previous year. Over the period under review, production of attained the maximum level at $X in 2020; however, from 2021 to 2022, production failed to regain momentum.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Slovakia

For the fourth consecutive year, Slovakia recorded decline in overseas shipments of other medicaments for therapeutic or prophylactic uses, which decreased by X% to X tons in 2022. Overall, exports continue to indicate a abrupt slump. The pace of growth appeared the most rapid in 2013 when exports increased by X% against the previous year. Over the period under review, the exports of hit record highs at X tons in 2018; however, from 2019 to 2022, the exports stood at a somewhat lower figure.

In value terms, exports of other medicaments for therapeutic or prophylactic uses fell remarkably to $X in 2022. In general, exports showed a abrupt setback. The most prominent rate of growth was recorded in 2014 when exports increased by X% against the previous year. Over the period under review, the exports of reached the peak figure at $X in 2018; however, from 2019 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

Canada (X tons) was the main destination for exports of other medicaments for therapeutic or prophylactic uses from Slovakia, with a X% share of total exports. Moreover, exports of other medicaments for therapeutic or prophylactic uses to Canada exceeded the volume sent to the second major destination, Italy (X tons), threefold. Poland (X tons) ranked third in terms of total exports with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume to Canada amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Italy (X% per year) and Poland (X% per year).

In value terms, Italy ($X), Canada ($X) and Poland ($X) appeared to be the largest markets for other medicaments for therapeutic or prophylactic uses exported from Slovakia worldwide, with a combined X% share of total exports.

Among the main countries of destination, Italy, with a CAGR of X%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2022, the average export price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, rising by X% against the previous year. Overall, export price indicated temperate growth from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, export price for other medicaments for therapeutic or prophylactic uses increased by X% against 2019 indices. The pace of growth was the most pronounced in 2014 when the average export price increased by X% against the previous year. Over the period under review, the average export prices attained the peak figure in 2022 and is likely to see gradual growth in the near future.

There were significant differences in the average prices for the major overseas markets. In 2022, amid the top suppliers, the country with the highest price was Germany ($X per ton), while the average price for exports to the Czech Republic ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Australia (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Slovakia

In 2022, approx. X tons of other medicaments for therapeutic or prophylactic uses were imported into Slovakia; which is down by X% compared with the previous year. In general, imports, however, enjoyed a notable increase. The pace of growth was the most pronounced in 2016 when imports increased by X%. Over the period under review, imports of attained the maximum at X tons in 2017; however, from 2018 to 2022, imports failed to regain momentum.

In value terms, imports of other medicaments for therapeutic or prophylactic uses contracted slightly to $X in 2022. Overall, imports saw a perceptible descent. The pace of growth appeared the most rapid in 2016 when imports increased by X% against the previous year. Over the period under review, imports of reached the peak figure at $X in 2017; however, from 2018 to 2022, imports failed to regain momentum.

Imports by Country

In 2022, the Czech Republic (X tons) constituted the largest supplier of other medicaments for therapeutic or prophylactic uses to Slovakia, accounting for a X% share of total imports. Moreover, imports of other medicaments for therapeutic or prophylactic uses from the Czech Republic exceeded the figures recorded by the second-largest supplier, the United States (X tons), threefold. Germany (X tons) ranked third in terms of total imports with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from the Czech Republic totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: the United States (X% per year) and Germany (X% per year).

In value terms, Germany ($X), the United States ($X) and the Czech Republic ($X) were the largest other medicaments for therapeutic or prophylactic uses suppliers to Slovakia, with a combined X% share of total imports. Hungary, India and Poland lagged somewhat behind, together comprising a further X%.

In terms of the main suppliers, Poland, with a CAGR of X%, recorded the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average import price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, rising by X% against the previous year. Overall, the import price, however, recorded a abrupt downturn. The import price peaked at $X per ton in 2012; however, from 2013 to 2022, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Hungary ($X per ton), while the price for Poland ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Germany (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :